Logistic model of likelihood of having high CD4 count above the cutoff point for pediatric patients younger than 20 years
| . | Variable . | Category . | n . | OR . | 99% CI . | P value . |
|---|---|---|---|---|---|---|
| Landmark model predicted by CD4 and IgA | ||||||
| Likelihood of having high day-100 CD4 count (>248 × 106/L) | ||||||
| Graft source | BM | 131 | 1.000 | — | .008 (2 df) | |
| PB | 70 | 3.524 | 1.235-10.054 | .002 | ||
| CB | 258 | 1.469 | 0.761-2.835 | .132 | ||
| GVHD prophylaxis | CNI | 307 | 1.000 | — | <.001 (3 df) | |
| CNI+ATG | 86 | 0.380 | 0.171-0.848 | .002 | ||
| TCD | 43 | 0.124 | 0.029-0.529 | <.001 | ||
| PTCy | 23 | 0.716 | 0.189-2.708 | .518 | ||
| Likelihood of having high day-180 CD4 count (>420 × 106/L) | ||||||
| Patient age, y | 293 | 0.905 | 0.837-0.980 | .001 | ||
| Graft Source | BM | 59 | 1.000 | — | .007 (2 df) | |
| PB | 38 | 0.928 | 0.164-5.265 | .912 | ||
| CB | 196 | 3.182 | 1.028-9.851 | .008 | ||
| Steroid use | No | 142 | 1.000 | — | ||
| Yes | 151 | 0.290 | 0.126-0.668 | <.001 | ||
| Landmark model predicted by CD4 only | ||||||
| Likelihood of having high day-180 CD4 count (>420 × 106/L) | ||||||
| Patient age, y | 447 | 0.928 | 0.873-0.987 | .002 | ||
| Graft source | BM | 127 | 1.000 | — | .004 (2 df) | |
| PB | 67 | 0.609 | 0.182-2.041 | .291 | ||
| CB | 253 | 2.031 | 0.975-4.232 | .013 | ||
| Steroid use | No | 251 | 1.000 | — | ||
| Yes | 196 | 0.350 | 0.178-0.691 | <.001 |
| . | Variable . | Category . | n . | OR . | 99% CI . | P value . |
|---|---|---|---|---|---|---|
| Landmark model predicted by CD4 and IgA | ||||||
| Likelihood of having high day-100 CD4 count (>248 × 106/L) | ||||||
| Graft source | BM | 131 | 1.000 | — | .008 (2 df) | |
| PB | 70 | 3.524 | 1.235-10.054 | .002 | ||
| CB | 258 | 1.469 | 0.761-2.835 | .132 | ||
| GVHD prophylaxis | CNI | 307 | 1.000 | — | <.001 (3 df) | |
| CNI+ATG | 86 | 0.380 | 0.171-0.848 | .002 | ||
| TCD | 43 | 0.124 | 0.029-0.529 | <.001 | ||
| PTCy | 23 | 0.716 | 0.189-2.708 | .518 | ||
| Likelihood of having high day-180 CD4 count (>420 × 106/L) | ||||||
| Patient age, y | 293 | 0.905 | 0.837-0.980 | .001 | ||
| Graft Source | BM | 59 | 1.000 | — | .007 (2 df) | |
| PB | 38 | 0.928 | 0.164-5.265 | .912 | ||
| CB | 196 | 3.182 | 1.028-9.851 | .008 | ||
| Steroid use | No | 142 | 1.000 | — | ||
| Yes | 151 | 0.290 | 0.126-0.668 | <.001 | ||
| Landmark model predicted by CD4 only | ||||||
| Likelihood of having high day-180 CD4 count (>420 × 106/L) | ||||||
| Patient age, y | 447 | 0.928 | 0.873-0.987 | .002 | ||
| Graft source | BM | 127 | 1.000 | — | .004 (2 df) | |
| PB | 67 | 0.609 | 0.182-2.041 | .291 | ||
| CB | 253 | 2.031 | 0.975-4.232 | .013 | ||
| Steroid use | No | 251 | 1.000 | — | ||
| Yes | 196 | 0.350 | 0.178-0.691 | <.001 |